Innovative Cellular Therapeutics Holdings reports Lyell Immunopharma share sale worth $137
LYEL•Lyell Immunopharma share sale disclosed
- Innovative Cellular Therapeutics Holdings Ltd disclosed a sale of 10 Lyell Immunopharma common shares on July 17, 2026.
- Shares were sold at $13.70 each, leaving the holder with 2,857,480 shares.
- The filing lists the seller as a 10% owner.
